Greenwich Lifesciences (GLSI)
Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company, develops novel cancer immunotherapies for breast cancer and other HER2/neu-expressing...
- Open
- 15.790
- High
- 16.340
- Low
- 14.900
- Prev. Close
- 15.900
- Volume
- 103.34K
- Turnover
- 1.58M
- Avg Price
- 15.281
- Bid/Ask Ratio
- -81.98%
- Amplitude
- 9.06%
- 52wk High
- 34.100
- Volume Ratio
- 0.31
- Turnover Ratio
- 1.35%
Greenwich Lifesciences Analyst Rating
View moreForecast & Rating
Jul 21, 2026Price forecast
$57.00279.24%
Forecast & RatingStrong buy
2analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Price Alert · Sep 1 at 01:21 AM
U.S. stock night market fluctuations: GLSI rose 10.23% in the night market with no significant positive news, attracting attention due to capital movement
- Market Beat · Aug 11 at 10:41 PM
Greenwich LifeSciences (NASDAQ:GLSI) Posts Quarterly Earnings Results
- PUBT · Aug 10 at 10:01 AM
Greenwich LifeSciences extends insider lock-up to Jan. 31, 2027
- Tip Ranks · Jul 31 at 02:05 AM
Top Executive Doubles Down on Greenwich LifeSciences With Fresh Insider Buy
